JAK2 inhibitor CEP-33779 prevents mouse oocyte maturation in vitro

Changli Wu1, Rong Li2, Haibing Luo1

  • 1Department of Physiology, Guangdong Medical University, Zhanjiang, Guangdong, People's Republic of China.

Bioscience Reports
|June 16, 2017
PubMed

Insights

Janus kinase 2 (JAK2) inhibition by CEP-33779 significantly impairs mouse oocyte maturation. This occurs due to disrupted microfilament organization, specifically the failure to form an actin cap, suggesting JAK2

Area of Science:

  • Reproductive Biology
  • Cell Signaling
  • Molecular Biology

Background:

  • Janus kinase 2 (JAK2) is crucial for signal transduction and cell cycle regulation in somatic cells.
  • The role of JAK2 in mammalian oocyte maturation remains largely unexplored.
  • Understanding JAK2's function is key to addressing potential infertility factors.

Purpose of the Study:

  • To investigate the effects of the JAK2 inhibitor CEP-33779 on mouse oocyte meiosis.
  • To elucidate the potential mechanisms by which JAK2 influences oocyte maturation.
  • To determine JAK2's localization during mouse oocyte maturation.

Main Methods:

  • Detection of JAK2 distribution within mouse oocytes during maturation.
  • Culture of mouse oocytes with CEP-33779.
  • Assessment of oocyte maturation rates, spindle morphology, and microfilament organization.

Main Results:

  • JAK2 was primarily localized in the cytoplasm of maturing oocytes.
  • CEP-33779 treatment significantly reduced the oocyte maturation rate (21.14% vs. 81.44% in controls).
  • Microfilament analysis revealed a failure to form an actin cap and inhibited maturation, while microtubule organization remained unaffected.

Conclusions:

  • CEP-33779 inhibits mouse oocyte maturation, likely by disrupting actin cap formation.
  • JAK2 plays a regulatory role in microfilament aggregation during oocyte maturation.
  • JAK2's involvement in cytoskeletal dynamics is critical for successful oocyte meiosis.